These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7460284)

  • 1. Sickle cell crisis as evaluated from measurements of hydroxybutyrate dehydrogenase and myoglobin in plasma.
    Roth EF; Bardfeld PA; Goldsmith SJ; Radel E; Williams JC
    Clin Chem; 1981 Feb; 27(2):314-6. PubMed ID: 7460284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ferritin concentration in sickle cell crisis.
    Brownell A; Lowson S; Brozović M
    J Clin Pathol; 1986 Mar; 39(3):253-5. PubMed ID: 3958215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-alpha-hydroxybutyrate dehydrogenase levels in sickle-cell disease and sickle-cell crisis.
    White JM; Billimoria F; Muller MA; Davis LR; Stroud CE
    Lancet; 1978 Mar; 1(8063):532-3. PubMed ID: 76073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-hydroxybutyrate dehydrogenase and the diagnosis of painful crisis in sickle cell anaemia.
    Akenzua GI; Ihongbe JC; Asemota HN
    Afr J Med Med Sci; 1992 Dec; 21(2):13-7. PubMed ID: 1308075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-hydroxybutyrate dehydrogenase levels in children with sickle cell disease.
    Karayalcin G; Lanzkowsky P; Kari AB
    Am J Pediatr Hematol Oncol; 1981; 3(2):169-71. PubMed ID: 7304859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in serum electrolytes and enzyme concentrations in patients with sickle cell disease.
    Nduka N; Kazem Y; Saleh B
    J Clin Pathol; 1995 Jul; 48(7):648-51. PubMed ID: 7560173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of laboratory parameters during sickle cell painful crisis: evidence compatible with dense red cell sequestration without thrombosis.
    Billett HH; Nagel RL; Fabry ME
    Am J Med Sci; 1988 Nov; 296(5):293-8. PubMed ID: 2973751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis.
    Francis RB
    Haemostasis; 1989; 19(2):105-11. PubMed ID: 2731776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker?
    Al-Humood S; Zueriq R; Al-Faris L; Marouf R; Al-Mulla F
    Arch Pathol Lab Med; 2014 May; 138(5):678-83. PubMed ID: 24786126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte sedimentation rate during steady state and painful crisis in sickle cell anemia.
    Lawrence C; Fabry ME
    Am J Med; 1986 Nov; 81(5):801-8. PubMed ID: 3776987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial function in patients with sickle cell anemia during and after sickle cell crises.
    Blum A; Yeganeh S; Peleg A; Vigder F; Kryuger K; Khatib A; Khazim K; Dauerman H
    J Thromb Thrombolysis; 2005 Apr; 19(2):83-6. PubMed ID: 16052296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis.
    Papadimitriou CA; Travlou A; Kalos A; Douratsos D; Lali P
    Acta Haematol; 1993; 89(4):180-3. PubMed ID: 8212998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma fibronectin in sickle cell disease.
    Bolarin DM; Adenuga AO
    Acta Haematol; 1986; 75(4):209-10. PubMed ID: 3096051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal sublingual microcirculation during painful crisis in sickle cell disease.
    van Beers EJ; Goedhart PT; Unger M; Biemond BJ; Ince C
    Microvasc Res; 2008 May; 76(1):57-60. PubMed ID: 18423765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosomes and neutrophil activation in sickle cell disease painful crisis.
    Schimmel M; Nur E; Biemond BJ; van Mierlo GJ; Solati S; Brandjes DP; Otten HM; Schnog JJ; Zeerleder S;
    Haematologica; 2013 Nov; 98(11):1797-803. PubMed ID: 23911704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increased CK, LDH and alpha-HBDH without myoglobin or CK-MB increase].
    Wieland E
    Internist (Berl); 1999 Jan; 40(1):105-8. PubMed ID: 10086307
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum-alpha-hydroxybutyrate dehydrogenase in sickle-cell disease.
    Fleming AF
    Lancet; 1978 Jul; 2(8079):46. PubMed ID: 78243
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemoglobin distribution width: a rapid assessment of dense red cells in the steady state and during painful crisis in sickle cell anemia.
    Billett HH; Fabry ME; Nagel RL
    J Lab Clin Med; 1988 Sep; 112(3):339-44. PubMed ID: 3411196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell disease painful crisis and steady state differentiation by proton magnetic resonance.
    Fernández AA; Cabal CA; Lores MA; Losada J; Pérez ER
    Hemoglobin; 2009; 33(3):206-13. PubMed ID: 19657834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.